In times of crisis, public media is needed more than ever. Help us continue delivering timely, fact-based journalism today.

Donate

Today’s Top Story

A glass vial in focus in the foreground, with gloved hands uncapping a needle blurry in the background.
FDA Advisers Vote Against Broad Pfizer COVID Booster — But Recommend for People 65 and Older
A panel of advisers to the Food and Drug Administration voted against a booster dose of the Pfizer-BioNTech COVID-19 vaccine being licensed for people 16 years and older.
Sponsored